Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1359 of 6351
-
Brain tumor drug delivered via pump shows promise in early trial
Disease control Recruiting nowThe primary goal of this study is to establish the safety of chronic Convection Enhanced Delivery (CED) of the chemotherapeutic drug Topotecan for patients with recurrent malignant glioma that harbors the Isocitrate Dehydrogenase mutation (IDH-mut). The secondary goal of the stud…
Phase 1 • Sponsor: Jeffrey N. Bruce • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New nerve graft could spare patients a second surgery
Disease control Recruiting nowThis is a multicenter, 1:1 randomized, prospective, comparative study in participants requiring reconstruction of a mixed or motor nerve in the upper extremity. This study will consist of a screening visit, an operative visit, and 9 post-operative follow-up visits at Week 4, and …
Phase 4 • Sponsor: Axogen Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI could help ultrasound spot ovarian cancer earlier
Diagnosis OngoingThe ASTOM study is a monocentric prospective observational pilot study conducted at the Gynecologic Oncology Unit of the IRCCS Azienda Ospedaliero-Universitaria of Bologna. This study is aimed at evaluating the application of artificial intelligence to ultrasound screening for ov…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Heated chemo during surgery may help fight stomach cancer spread
Disease control Recruiting nowThis trial will administer laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis from gastric cancer (GPC) who are receiving standard of care systemic chemotherapy.
Phase 2 • Sponsor: Mohammad Haroon Asif Choudry • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill combo offers hope for older leukemia patients who Can't handle chemo
Disease control Recruiting nowThe goal of this clinical trial is to learn if the combination of oral decitabine plus ivosidenib works to treat naïve adult patients with acute myeloid leukemia (AML) with IDH1 R132 mutation older than 60 years old or those who are older than 18 years old with defined comorbidit…
Phase 2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Smart radiation: new trial aims to zap lingering lymphoma cells
Disease control Not yet recruitingThis prospective feasibility study evaluates a minimal residual disease (MRD)-adapted treatment strategy in patients with diffuse large B-cell lymphoma (DLBCL) receiving frontline chemoimmunotherapy. Circulating tumor DNA (ctDNA)-based MRD testing and interim positron emission to…
Phase 2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can brain training lift the weight of depression in kidney disease?
Symptom relief Recruiting nowThe purpose of this research is to evaluate the feasibility and effectiveness of Digital Neurotherapy (DNT) or Capacity Coaching (CC) for managing symptoms of depression and self reported pain in Autosomal Dominant Polycystic Kidney Disease (ADPKD) compared to education alone.
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Pharmacists join fight against lung cancer with simple blood test
Diagnosis Recruiting nowThe U.S. Preventive Services Task Force recommends annual lung cancer screening (LCS) with low-dose CT for adults aged 50-80 with a ≥20 pack-year smoking history who currently smoke or quit within the past 15 years. Despite insurance coverage, only 17% of eligible Iowans were scr…
Sponsor: Jill Kolesar • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
CBD may cut opioid need in advanced prostate cancer
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate the effects of cannabidiol in patients with end-stage metastatic castration-resistant prostate cancer (mCRPC). The primary objective is to determine whether cannabidiol (CBD) treatment can reduce the need for opioids in patients wit…
Phase 2 • Sponsor: Regionshospital Nordjylland • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New hope for tough lymphoma: experimental drug GSK5926371 enters human trials
Disease control Not yet recruitingThe goal of this clinical trial is to learn if drug GSK5926371 works to treat a form of B-cell cancer (a type of blood cancer) that has returned or failed to respond to prior therapies in adults. The study will primarily assess the drugs safety and tolerability in participants. A…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to restore strength in aging muscles
Disease control Recruiting nowThis study is a randomized, double-blind, multicenter, placebo parallel-controlled Phase II clinical study designed to evaluate the clinical efficacy and safety of TJ0113 Capsule in patients with sarcopenia. The entire study plans to enroll 204 participants with sarcopenia. Eligi…
Phase 2 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Smart oxygen device could help preterm babies breathe easier
Disease control Recruiting nowThis randomised controlled trial aims to investigate the effectiveness of closed-loop automated oxygen control (CLAC) in preterm infants receiving non-invasive respiratory support and determine if it reduces the duration of supplementary oxygen treatment and improves achievement …
Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a phone app be the key to managing kidney disease?
Knowledge-focused Recruiting nowThis study evaluates disease progression and management characteristics in patients with chronic kidney disease (CKD) using an integrated mobile application and hospital information system (HIS) clinical data. The main goals of this study are: 1. To observe patient self-managem…
Sponsor: Chungnam National University Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Dissolvable magnesium stent could revolutionize heart disease treatment
Disease control Recruiting nowThe objective of this study is to assess the safety and efficacy of the Freesolve resorbable magnesium scaffold (RMS) in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to the Xience coronary drug-eluting stent (DES) system
Sponsor: Teleflex • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could earlier breathing help in ALS? new trial aims to find out
Disease control Recruiting nowAmyotrophic lateral sclerosis (ALS) is a disease that causes weakness of the muscles of the body. The disease can eventually lead to severe breathing problems, which is the most common cause of death from ALS. The treatment for breathing is non-invasive ventilation (NIV). It is a…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill aims to fight Obesity-Linked inflammation
Disease control Recruiting nowThe purpose of this study is to learn about the effects of BGE-102 on blood biomarkers including hsCRP, which is a lab value used to measure inflammation. BGE-102 decreases inflammation which may improve obesity and cardiovascular health. Participants will receive either BGE-102 …
Phase 2 • Sponsor: BioAge Labs, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug TAK-360 tested for Long-Term safety in sleep disorders
Disease control Recruiting nowCentral hypersomnia conditions are a group of sleeping disorders where the brain has trouble keeping a person awake during the day (called excessive daytime sleepiness or EDS). These conditions usually include narcolepsy (type 1 and 2) and idiopathic hypersomnia (IH). Narcolepsy …
Phase 2/3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Bacteria in the mouth and gut may predict who responds to cancer immunotherapy
Knowledge-focused Recruiting nowThis is a prospective observational cohort study conducted at Fundación CTIC in Bogotá, Colombia. It characterizes the oral, fecal and intratumoral microbiome of Colombian adults with advanced solid tumors (gastric, colorectal, breast, cervical and head-and-neck cancer) who recei…
Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New oral drug INT-210 aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowA Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants with Active Ulcerative Colitis. The study aims to evaluate the safety, efficacy, pharmacokinetic (PK) characteristics, pharmacodynamic (PD) characteristic…
Phase 1/2 • Sponsor: Innatus Therapeutics (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a diabetes drug curb alcohol cravings and save livers?
Disease control Recruiting nowBackground: People with alcohol use disorder (AUD) often develop metabolic alcohol-associated liver disease (MetALD). MetALD is a term for the heart, liver, obesity, and other issues that can accompany AUD. MetALD can be fatal. An approved weight management drug (Tirzepatide) ma…
Phase 2 • Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC